Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001708599-25-000085

Chief Scientific Officer sold 5,500 shares at $5.17 ($28,435)

  • Chief Scientific Officer acquired 5,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Moreadith Randall Chief Scientific Officer 2025-08-04 Option exercise 10b5-1 +5,500 $0.06 $330 5,500 D
Moreadith Randall Chief Scientific Officer 2025-08-04 Sale 10b5-1 −5,500 $5.17 $28,435 0 D
Derivatives
Moreadith Randall Chief Scientific Officer 2025-08-04 Option exercise · Stock Option (right to buy) 10b5-1 −5,500 478,990 D
Open-market sales · 5,500 sh · avg $5.17 · $28,435
Loading xslF345X05/wk-form4_1754515343.xml…